Omega Funds
Signal active
Investment Firm
Overview
Omega Funds is a venture capital firm that seeks to invest in the life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and SaaS sectors.
Highlights
Founded
2004
Industry
Financial Services
Employees
11-50
Investment
140
Lead Investment
32
Exits
63
Stages
Late Stage Venture, Early Stage Venture, Private Equity, Seed
Investor Type
Venture Capital
Location
Geneva, Geneve, Switzerland, Europe
Contact Information
Social
Profile Resume
Omega Funds, established in 2004 and headquartered in Switzerland, Europe., specializes in Late Stage Venture, Early Stage Venture, Private Equity, Seed investments across Biotechnology, Pharmaceutical, Diabetes, Financial Services, Venture Capital, Finance, Life Science, Health Care, Oncology, Medical Device. The organization boasts a portfolio of 135 investments, with an average round size of $88.0M and 63 successful exits. Their recent investments include Elixir Pharmaceuticals, ARCH Venture Partners, MPM Capital, Oxford Bioscience Partners, Intarcia Therapeutics. The highest investment round they participated in was $1406.1B. Among their most notable exits are Elixir Pharmaceuticals and ARCH Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Omega Funds has made 140 investments. Their most recent investment was on Jul 24, 2024, when Kestra Medical Technologies, Inc. raised $196.0M.
Omega Funds has made 25 diversity investments. Their most recent diversity investment was on Mar 06, 2024, when Alumis raised $259.0M.
investments
140
Diversity investments
25
Lead investments
32
Number of exits
63
Investments
140
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 16, 2024 | - | - | 150.0M |
| Jul 16, 2024 | Scorpion Therapeutics | Biotechnology | 150.0M |
| Jul 23, 2024 | - | - | 165.0M |
| Jul 24, 2024 | Kestra Medical Technologies, Inc. | Health Care | 196.0M |
Exits
63
Funding Timeline
Funding rounds
140
Investors
0
Funds
6
Funding Rounds
140
Omega Funds has raised 140 rounds. Their latest funding was raised on Jul 24, 2024 from a Private Equity Round - Kestra Medical Technologies, Inc. round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 16, 2024 | Series D - CatalYm | - | 150.0M | - |
| Jul 16, 2024 | Series C - Scorpion Therapeutics | - | 150.0M | - |
| Jul 23, 2024 | Series A - Third Arc Bio | - | 165.0M | - |
| Jul 24, 2024 | Private Equity Round - Kestra Medical Technologies, Inc. | - | 196.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
Jul 24, 2024
Kestra Medical Technologies, Inc. raised $196000000 on 2024-07-24 in Private Equity Round
Funding Round
Jul 23, 2024
Third Arc Bio raised $165000000 on 2024-07-23 in Series A
News
Jul 16, 2024
Life-Sciences-Germany - Catalym–Stampacchia O: board, 202407– board director main org Omega Funds
Funding Round
Jul 16, 2024
Scorpion Therapeutics raised $150000000 on 2024-07-16 in Series C
Funding Round
Jul 16, 2024
CatalYm raised $150000000 on 2024-07-16 in Series D
Funding Round
Jun 18, 2024
Marea Therapeutics raised $190000000 on 2024-06-18 in Series B